Viw Magazine

The Times Real Estate

.

Constantly Strategical Planning High-Growth Sectors, Grand Pharma’s 2022 Interim Results Continue to Grow

  • Written by Viw Magazine

HONG KONG SAR - Media OutReach - 11 August 2022- Grand Pharma (0512.HK, the "Company") announced its 2022 interim results recently. During the first half of 2022 (the "Period"), the Company recorded revenue of approximately HKD 5.21 billion, representing an increase of 14.1% YoY; net profit attributable to owners of the company of HKD 1.09 billion (excluding the changes in investment in Telix), representing an increase of 20.1% YoY.

Read more

LifeStyle

Australian River Fishing Just Got Eco Friendly with Pontoon Boats

If you enjoy fishing and long for relaxing days on the water, you might want to consider investing...

Why Australia Is Embracing Sustainable Commuting: The Rise of Electric Bicycles and Scooters

Source: NGMobility Australia’s cities are changing as more people look for cleaner ways to get ...

Finding Your Perfect Fit: The Importance of a Good Sports Bra and Knowing Your Size

For anyone who enjoys being active, a supportive sports bra isn't just an accessory – it's esse...

The Ultimate Guide to Jumping Castles and Playground Structures for Your Back Yard

Australia is renowned for its love of outdoor fun and family time. If you’re looking to create a s...